Clinical trial
A Clinical Study on Absorption, Metabolism, and Excretion of [14C]HSK31858 in Healthy Adult Male Chinese Subjects - Mass Balance and Biotransformation of [14C]HSK31858 in Human.
NCT06569784 is registered in ClinicalTrials.gov with Xizang Haisco Pharmaceutical Co., Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Clinical Study on Absorption, Metabolism, and Excretion of [14C]HSK31858 in Healthy Adult Male Chinese Subjects - Mass Balance and Biotransformation of [14C]HSK31858 in Human.
- Lead sponsor
- Xizang Haisco Pharmaceutical Co., Ltd
- Phase
- Phase 1
- Overall status
- Active, not recruiting
- Start date
- May 30, 2024
- Completion date
- October 30, 2024
- Enrollment
- 6 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy